Influence of age, past smoking, and disease severity on tlr2, neutrophilic inflammation, and MMP-9 Levels in COPD

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Simpson, Jodie L ^a,b   McDonald, Vanessa M ^a,b   Baines, Katherine J ^a,b   Oreo, Kevin M ^a,b   Wang, Fang ^c   Hansbro, Philip M ^b   Gibson, Peter G ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c Basic Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MESSENGER RNA; TIOTROPIUM BROMIDE; TOLL LIKE RECEPTOR 2; TLR2 PROTEIN, HUMAN;

ADULT; AGE; AGING; ARTICLE; BRONCHITIS; CELL ASSAY; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DISEASE SEVERITY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; NEUTROPHIL; NEUTROPHIL COUNT; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SPUTUM; AGED; ENZYMOLOGY; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGE FACTORS; AGED; FEMALE; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOLL-LIKE RECEPTOR 2;

EID: 84877305183     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/462934     Document Type: Article

References (44)

1. Buist A. S., McBurnie M. A., Vollmer W. M., Gillespie S., Burney P., Mannino D. M., Menezes A. M., Sullivan S. D., Lee T. A., Weiss K. B., Jensen R. L., Marks G. B., Gulsvik A., Nizankowska-Mogilnicka E., International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. The Lancet 2007 370 9589 741 750 2-s2.0-34548267728 10.1016/S0140-6736(07) 61377-4 (Pubitemid 47321907)
2. Keely S., Talley N. J., Hansbro P. M., Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunology 2012 5 1 7 18
3. Pauwels R. A., Buist A. S., Calverley P. M. A., Jenkins C. R., Hurd S. S., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. American Journal of Respiratory and Critical Care Medicine 2001 163 5 1256 1276 2-s2.0-0035035768 (Pubitemid 32378468)
4. Agusti A., Barnes P. J., What the journal would like to publish on chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2010 182 1 1 2 2-s2.0-77955887691 10.1164/rccm.201004- 0616ED
5. Simpson J. L., Grissell T. V., Douwes J., Scott R. J., Boyle M. J., Gibson P. G., Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007 62 3 211 218 2-s2.0-33947588653 10.1136/thx.2006. 061358
6. Baines K. J., Simpson J. L., Gibson P. G., Innate immune responses are increased in chronic obstructive pulmonary disease. PLoS One 2011 6 3 2-s2.0-79953646075 10.1371/journal.pone.0018426 e18426
7. Droemann D., Goldmann T., Tiedje T., Zabel P., Dalhoff K., Schaaf B., Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respiratory Research 2005 6 article 68 2-s2.0-26244461463 10.1186/1465-9921-6-68 (Pubitemid 41410167)
8. Von Scheele I., Larsson K., Dahlén B., Billing B., Skedinger M., Lantz A. S., Palmberg L., Toll-like receptor expression in smokers with and without COPD. Respiratory Medicine 2011 105 8 1222 1230 2-s2.0-79959284858 10.1016/j.rmed.2011.02.012
9. Ware J. E., Sherbourne C. D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992 30 6 473 483 2-s2.0-0026877917
10. Ferris B. G., Epidemiology Standardization Project (American Thoracic Society). American Review of Respiratory Disease 1978 118 6 1 120 2-s2.0-0018068101
11. Sato S., Nishimura K., Koyama H., Tsukino M., Oga T., Hajiro T., Mishima M., Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest 2003 124 5 1749 1754 2-s2.0-0242552192 10.1378/chest.124.5.1749 (Pubitemid 37433568)
12. Knudson R. J., Slatin R. C., Lebowitz M. D., Burrows B., The maximal expiratory flow volume curve. Normal standards, variability, and effects of age. American Review of Respiratory Disease 1976 113 5 587 600 2-s2.0-0017198614
13. American Thoracic Society, Single-breath carbon monoxide diffusing capacity (Transfer Factor). American Journal of Respiratory and Critical Care Medicine 1995 152 2185 2198
14. Gibson P. G., Wlodarczyk J. W., Hensley M. J., Gleeson M., Henry R. L., Cripps A. W., Clancy R. L., Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. American Journal of Respiratory and Critical Care Medicine 1998 158 1 36 41 2-s2.0-0031847645 (Pubitemid 28337155)
15. Grissell T. V., Powell H., Shafren D. R., Boyle M. J., Hensley M. J., Jones P. D., Whitehead B. F., Gibson P. G., Interleukin-10 gene expression in acute virus-induced asthma. American Journal of Respiratory and Critical Care Medicine 2005 172 4 433 439 2-s2.0-23644441525 10.1164/rccm.200412-1621OC (Pubitemid 41117388)
16. Schröder A. K., Rink L., Neutrophil immunity of the elderly. Mechanisms of Ageing and Development 2003 124 4 419 425 2-s2.0-0037397899 10.1016/S0047-6374(03)00017-4 (Pubitemid 36514896)
17. Thomas R. A., Green R. H., Brightling C. E., Birring S. S., Parker D., Wardlaw A. J., Pavord I. D., The influence of age on induced sputum differential cell counts in normal subjects. Chest 2004 126 6 1811 1814 2-s2.0-10444239309 10.1378/chest.126.6.1811 (Pubitemid 39643984)
18. Fulop T., Larbi A., Douziech N., Fortin C., Guérard K. P., Lesur O., Khalil A., Dupuis G., Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004 3 4 217 226 2-s2.0-5644265023 10.1111/j.1474-9728.2004.00110.x (Pubitemid 40246686)
19. Boyd A. R., Shivshankar P., Jiang S., Berton M. T., Orihuela C. J., Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. Experimental Gerontology 2012 47 7 507 518 10.1016/j.exger.2012.04.004
20. Chalmers G. W., MacLeod K. J., Thomson L., Little S. A., McSharry C., Thomson N. C., Smoking and airway inflammation in patients with mild asthma. Chest 2001 120 6 1917 1922 2-s2.0-0035684297 10.1378/chest.120.6.1917 (Pubitemid 34053454)
21. Ilumets H., Mazur W., Toljamo T., Louhelainen N., Nieminen P., Kobayashi H., Ishikawa N., Kinnula V. L., Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulmonary Medicine 2011 11 article 19 2-s2.0-79955113393 10.1186/1471-2466-11-19
22. Louhelainen N., Stark H., Mazur W., Rytilä P., Djukanovic R., Kinnula V. L., Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC Pulmonary Medicine 2010 10 article 13 2-s2.0-77949446867 10.1186/1471-2466-10-13
23. Ilumets H., Rytilä P., Demedts I., Brusselle G. G., Sovijärvi A., Myllärniemi M., Sorsa T., Kinnula V. L., Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD. International Journal of COPD 2007 2 3 369 379 2-s2.0-36148964049 (Pubitemid 350110911)
24. Wark P. A. B., Saltos N., Simpson J., Slater S., Hensley M. J., Gibson P. G., Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. European Respiratory Journal 2000 16 6 1095 1101 2-s2.0-0034483538 10.1034/j.1399-3003.2000.16f13.x (Pubitemid 32148124)
25. Simpson J. L., Scott R., Boyle M. J., Gibson P. G., Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006 11 1 54 61 2-s2.0-33645101537 10.1111/j.1440-1843.2006.00784.x
26. Vernooy J. H. J., Lindeman J. H. N., Jacobs J. A., Hanemaaijer R., Wouters E. F. M., Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 2004 126 6 1802 1810 2-s2.0-10444274041 10.1378/chest.126.6.1802 (Pubitemid 39643983)
27. Culpitt S. V., Rogers D. F., Traves S. L., Barnes P. J., Donnelly L. E., Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respiratory Medicine 2005 99 6 703 710 2-s2.0-18244396326 10.1016/j.rmed.2004.10.022 (Pubitemid 40631296)
28. Simpson J. L., Scott R. J., Boyle M. J., Gibson P. G., Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. American Journal of Respiratory and Critical Care Medicine 2005 172 5 559 565 2-s2.0-24144482766 10.1164/rccm.200503-369OC (Pubitemid 41232966)
29. Masure S., Proost P., Van Damme J., Opdenakker G., Purification and identification of 91-kDa neutrophil gelatinase. release by the activating peptide interleukin-8. European Journal of Biochemistry 1991 198 2 391 398 2-s2.0-0025808816
30. Nakamura H., Yoshimura K., McElvaney N. G., Crystal R. G., Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. Journal of Clinical Investigation 1992 89 5 1478 1484 2-s2.0-0026681802
31. Adcock I. M., Ford P., Ito K., Barnes P. J., Epigenetics and airways disease. Respiratory Research 2006 7 article 21 2-s2.0-33644549630 10.1186/1465-9921-7-21
32. Pavord I. D., Birring S. S., Berry M., Green R. H., Brightling C. E., Wardlaw A. J., Multiple inflammatory hits and the pathogenesis of severe airway disease. European Respiratory Journal 2006 27 5 884 888 2-s2.0-33845478528 10.1183/09031936.06.00128105 (Pubitemid 44911098)
33. Fattahi F., Ten Hacken N. H., Lofdahl C. G., Hylkema M. N., Timens W., Postma D. S., Vonk J. M., Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respiratory Research 2013 14 article 10 10.1186/1465-9921-14-10
34. Soler-Cataluna J. J., Cosio B., Izquierdo J. L., Lopez-Campos J. L., Marin J. M., Aguero R., Baloira A., Carrizo S., Esteban C., Galdiz J. B., Gonzalez M. C., Miravitlles M., Monso E., Montemayor T., Morera J., Ortega F., Peces-Barba G., Puente L., Rodriguez J. M., Sala E., Sauleda J., Soriano J. B., Viejo J. L., Consensus document on the overlap phenotype COPD-asthma in COPD. Archivos de Bronconeumología 2012 48 9 331 337
35. Janeway C. A. Jr., Medzhitov R., Innate immune recognition. Annual Review of Immunology 2002 20 197 216 2-s2.0-0036212849 10.1146/annurev.immunol.20. 083001.084359 (Pubitemid 34293424)
36. Reed C. E., Milton D. K., Endotoxin-stimulated innate immunity: a contributing factor for asthma. Journal of Allergy and Clinical Immunology 2001 108 2 157 166 2-s2.0-0034904034 10.1067/mai.2001.116862 (Pubitemid 32735395)
37. Sabroe I., Lloyd C. M., Whyte M. K. B., Dower S. K., Williams T. J., Pease J. E., Chemokines, innate and adaptive immunity, and respiratory disease. European Respiratory Journal 2002 19 2 350 355 2-s2.0-0036175191 10.1183/09031936.02.00253602 (Pubitemid 34162839)
38. Baines K. J., Simpson J. L., Scott R. J., Gibson P. G., Immune responses of airway neutrophils are impaired in asthma. Experimental lung research 2009 35 7 554 569 2-s2.0-75549087844
39. Lee Y., Kim H., Kim S., Kim K. H., Chung J. H., Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF- γ B in human epidermal keratinocytes. Experimental Dermatology 2010 19 8 e44 e49 2-s2.0-77954840281 10.1111/j.1600-0625.2009.00963.x
40. Shuto T., Imasato A., Jono H., Sakai A., Xu H., Watanabe T., Rixter D. D., Kai H., Andalibi A. M., Linthicum F., Guan -L Y., Han J., Cato A. C. B., Lim D. J., Akira S., Li -D J., Glucocorticoids synergistically enhance nontypeable Haemophilus influzenae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP Kinase. The Journal of Biological Chemistry 2002 277 17263 17270 (Pubitemid 34967761)
41. Homma T., Kato A., Hashimoto N., Batchelor J., Yoshikawa M., Imai S., Wakiguchi H., Saito H., Matsumoto K., Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2004 31 4 463 469 2-s2.0-4944240246 10.1165/rcmb.2004-0161OC (Pubitemid 39330957)
42. Winder A. A., Wohlford-Lenane C., Scheetz T. E., Nardy B. N., Manzel L. J., Look D. C., McCray P. B., Differential effects of cytokines and corticosteroids on Toll-like receptor 2 expression and activity in human airway epithelia. Respiratory Research 2009 10 article 96 2-s2.0-73949099857 10.1186/1465-9921-10-96
43. Essilfie A.-T., Simpson J. L., Dunkley M. L., Morgan L. C., Oliver B. G., Gibson P. G., Foster P. S., Hansbro P. M., Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 2012 67 7 588 599 10.1136/thoraxjnl- 2011-200160
44. Poole J. A., Wyatt T. A., Kielian T., Oldenburg P., Gleason A. M., Bauer A., Golden G., West W. W., Sisson J. H., Romberger D. J., Toll-like receptor 2 regulates organic dust-induced airway inflammation. American Journal of Respiratory Cell and Molecular Biology 2011 45 4 711 719 10.1165/rcmb.2010- 0427OC